Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Maggio, E.
Right arrow Articles by Poppema, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maggio, E.
Right arrow Articles by Poppema, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:52-56, 2002
© 2002 European Society for Medical Oncology

Chemokines, cytokines and their receptors in Hodgkin's lymphoma cell lines and tissues

E. Maggio1, A. van den Berg1, A. Diepstra1, J. Kluiver1, L. Visser1 and S. Poppema1

1 Department of Pathology and Laboratory Medicine, University Hospital Groningen, Groningen, The Netherlands

Abstract

Background: Hodgkin's lymphoma (HL) is characterized by a minority of neoplastic cells, the so-called Reed–Sternberg (RS) cells, and an admixture of reactive cells including lymphocytes, plasma cells, eosinophils and histiocytes. Cytokines produced in HL, either by RS or infiltrating cells, might explain the presence and maintenance of an impaired immune response. Chemokines (cytokines with chemoattractant properties) produced by RS cells play a major role in leukocyte trafficking. These molecules with specific receptor affinities contribute, for example by attracting TH2-like T cells, to the maintenance of a favorable environment for survival of RS cells.

Results and discussion: Cross-talk between RS cells and reactive elements involves several cytokine/chemokines that process proliferative [interleukin (IL)-13 and IL-17], immunosuppressive (IL-10 and transforming growth factor-ß) and background formation (IL-5, TARC, MDC, IP-10, RANTES, Mig and others) messages. These autocrine and paracrine interactions lead to an environment where RS cells are able to proliferate, escape from apoptosis and survive host anti-tumor defense.

Conclusions: The proper modulation of these complex pathways may allow the development of new strategies in HL therapy.

chemokine; cytokine; Hodgkin's lymphoma; IL-10; TARC; TGF-ß


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The OncologistHome page
K. J. Savage
Primary mediastinal large B-cell lymphoma.
Oncologist, May 1, 2006; 11(5): 488 - 495.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. C. Straathof, A. M. Leen, E. L. Buza, G. Taylor, M. H. Huls, H. E. Heslop, C. M. Rooney, and C. M. Bollard
Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV-Positive Nasopharyngeal Carcinoma and Lymphoma
J. Immunol., September 15, 2005; 175(6): 4137 - 4147.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
D. Re, R. Kuppers, and V. Diehl
Molecular Pathogenesis of Hodgkin's Lymphoma
J. Clin. Oncol., September 10, 2005; 23(26): 6379 - 6386.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. J. Liu, R. W. Huang, D. J. Lin, J. Peng, X. Y. Wu, Q. Lin, X. L. Pan, Y. Q. Song, M. H. Zhang, M. Hou, et al.
Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-{gamma} ligands induces apoptosis on human myeloid leukemia cells in vitro
Ann. Onc., March 1, 2005; 16(3): 455 - 459.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Alvaro, M. Lejeune, M. T. Salvado, R. Bosch, J. F. Garcia, J. Jaen, A. H. Banham, G. Roncador, C. Montalban, and M. A. Piris
Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells
Clin. Cancer Res., February 15, 2005; 11(4): 1467 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. J. Savage, S. Monti, J. L. Kutok, G. Cattoretti, D. Neuberg, L. de Leval, P. Kurtin, P. D. Cin, C. Ladd, F. Feuerhake, et al.
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
Blood, December 1, 2003; 102(12): 3871 - 3879.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
V. A. Thomazy, F. Vega, L. J. Medeiros, P. J. Davies, and D. Jones
Phenotypic Modulation of the Stromal Reticular Network in Normal and Neoplastic Lymph Nodes: Tissue Transglutaminase Reveals Coordinate Regulation of Multiple Cell Types
Am. J. Pathol., July 1, 2003; 163(1): 165 - 174.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.